SUMMARY A three-dimensional model of human renin has been constructed based on the assumption that the overall folding of the aspartyl proteases is very similar. As a reference, we used penicillopepsin, the structure of which has been reported at a resolution of 1.8 A, and its main chain was traced to build a model of renin. The resulting structure seems to be stable from the hydrophobic and hydrophilic viewpoints. Comparison of the tertiary structure of human renin with that of penicillopepsin and mouse renin suggests the existence of a high structural homology as well as differences in the molecular geometry of the active sites that may influence the substrate specificity. The asparagine side chains in the glycosidation signal of Asn-X-Thr are exposed on the surface. Moreover, the site in human renin that corresponds to the proteolytic cleavage site in mouse renin also appears to be exposed on the surface so as to be easily scissored during the maturation process. The insertions and deletions of amino acid residues were found to arise on the surface, and in some places they occurred in complementary manners. Models of molecular complexes between human renin and renin inhibitor were constructed to understand the interacting modes that indicate how new renin inhibitors develop. Inhibitor-binding sites were directly assigned based on the models of the inhibitor-enzyme complex. (Hypertension 7: 3-12, 1985) KEY WORDS • tertiary structure • active site • model building • human renin • aspartyl protease • penicillopepsin * drug design • hypertension * renin inhibitor R ENIN is an aspartyl protease involved in the regulation of blood pressure and electrolyte , homeostasis. As abnormalities in the level of circulating renin contribute to certain forms of hypertension, the enzyme has been a target in the development of antihypertensive drugs.
R
ENIN is an aspartyl protease involved in the regulation of blood pressure and electrolyte , homeostasis. As abnormalities in the level of circulating renin contribute to certain forms of hypertension, the enzyme has been a target in the development of antihypertensive drugs. 12 Determination of the three-dimensional structure and the subsequent characterization of the active site residues of renin are essential in understanding its unique specificity and catalytic mechanism and in designing and screening new types of specific inhibitors that are orally active and can be widely applied in the treatment of human hypertension.
The crystallization and preliminary x-ray diffraction analysis of mouse submandibular gland renin at 5 A resolution has been reported. 3 At this stage of the analysis, however, there is little information about the tertiary structure of the enzyme. Moreover, differences between mouse and human renin have been noted [n substrate specificities and amino acid sequences. For example, human renin can cleave both human and mouse angiotensinogen, while mouse renin cannot hydrolyze human substrate, and only 68% of the sequence homology is shared by the two enzymes. 4 These observations indicate that the geometry of the active sites may also be substantially different, which necessitates building a model of human renin.
It has been suggested that if the primary structure of human renin could be determined, a sufficiently accurate spatial model could be constructed from information about the structure of penicillopepsin, one of the well-characterized members of the aspartyl protease family that has recently been defined at 1.8 A resolution. 5 This suggestion is based on the following facts: (1) X-ray diffraction experiments have shown that, except for small deviations, there is a striking similarity among the structures of the various aspartyl proteases. 6 (2) Topological comparisons of other classes of proteins, such as serine proteinases 7 and bacterial sugar-binding proteins, 8 have also shown that the ex-HYPERTENSION VOL 7, No 1, JANUARY-FEBRUARY 1985 tent of the similarity in the a-carbon backbone coordinates is greater than that expected from the primary sequence homology. ( 3) The polypeptide chains of active human renin and penicillopepsin are of similar length, and clusters of highly homologous residues are distributed throughout the polypeptide chains in the same order at almost identical positions, 4 which suggests that the folding of the main chains proceeds in a similar way. (4) A three-dimensional model of mouse submandibular renin, which was shown to be representative of the actual structure of mouse renin, has recently been constructed by tracing the structure of Endothia parasitica pepsin with interactive computer graphics techniques. 9 The amino acid sequence of human kidney renin deduced from its cDNA sequence has been described previously. 4 This paper reports on the three-dimensional structure of renin, taking account of the high tertiary structural homology of human renin with penicillopepsin. The three-dimensional model of human renin should make a valuable contribution to the development of new drugs and analysis of the catalytic mechanism of renin.
Materials and Methods
The main chain of penicillopepsin, an aspartyl protease produced by the mold Penicillium janthanellum, was traced to determine the three-dimensional structure of human renin. Model building was carried out with the Hinomoto Goseijushi Seisakusho (HGS) biochemistry molecular models obtained from Maruzen Co., Ltd (Tokyo, Japan). Bond angles and bond lengths were approximated to those of the HGS models, and the torsion angles of the polypeptide chain were calculated from the coordinates of penicillopepsin (PDB-ID 2APP) 10 from the Protein Data Bank (Brookhaven National Laboratory, Upton, NY)," on the assumption that the three-dimensional structure of human renin resembles that of penicillopepsin. The places of insertion and deletion in the primary structure of human renin, with reference to penicillopepsin, were determined by sequence alignment with the method of Sellers. 12 Substrate-binding sites were assigned based on model fitting of the inhibitors Boc-Phe-His-Sta-Leu-(4-amido-1 -benzylpiperidine) (Compound II) and Z-[3-(l'-naphthyl)Ala]-His-Leucinal (Compound III) to the protein model, with the assumption that the conformation and interacting mode are similar to the pepstatin derivative (Iva)-Val-Val-Sta-OEt (Compound I) in the complex with penicillopepsin ( Figure I ). 13 The model was designed to include as many hydrogen bonds between inhibitor and enzyme as possible.
There are six cysteine residues in human renin. 4 Cys 51-Cys 58 and Cys 259-Cys 296 were included as cystine in the model. Cys 217 and Cys 221, which are remote from the active site and contained in the /3-structure of strand m of sheet III, were assumed to be cysteine because they were involved in the formation of a stable antiparallel /3-sheet. Misono 
Results and Discussion Sequence Homology of Renin and the Aspartyl Proteases
The sequential homologies among aspartyl proteases are shown in Table 1 . Mouse submandibular gland renin appears to be most homologous to human renin (68%) followed by porcine pepsin (41%). Although the homology between human renin and penicillopepsin was low (25%), we used this enzyme as the reference because x-ray study of its structure and refinement has been performed at high resolution (1.8 A).
5 An x-ray diffraction analysis of the molecular complex between penicillopepsin and an inhibitor of the aspartyl proteases has also been earned out at high resolution (1.8 A). 13 These studies are useful in calculating the subsequent design of renin inhibitors.
The alignment of the human renin sequence with the penicillopepsin sequence is shown in Table 2 . The alignment of the human renin sequence with those of other aspartyl proteases is also given in Table 2 . When the human renin sequence was aligned to maximize homology with penicillopepsin, it was necessary to introduce 10 insertions (27 residues) and 8 deletions (10 residues). The most striking feature of the human renin sequence was the presence of the insertion of four prolines (Pro 306, 307, 308, and 311). It occurred in the top edge of the cleft in which the catalytically important Asp 38 and Asp 226 are located. Porcine pepsin has a counterpart corresponding to this region, in which only one proline (293 in pepsin number) is included. This anomalous proline insertion also has been found in the mouse renin sequence. 9 We found insertions and deletions of amino acid residues in human renin with reference to penicillopepsin predominantly on the surface of the molecule. Many of the insertions and deletions occurred at the ends of loops, and 24 of the 37 amino acids related to the insertions and deletions appeared in places with large B-factors in the three-dimensional structure of penicillopepsin.
3 From these findings, it seems possible that insertions and deletions are likely to occur in the areas where the conformational change of chains takes place. Furthermore, we found that in some places insertions occurred complementanly with deletions to maintain the volume in the contact regions. 
Structural Characteristics
Figures 2, 3, and 4 show the three-dimensional structures of human renin. General descriptions of the structures are given in the figure legends. Although the homology of the primary structures between human renin and penicillopepsin is relatively low (25%; see Table 1 ), it is apparent that there is a similarity in the three-dimensional arrangement of the hydrophobic and hydrophilic amino acid side chains. Thus, many hydrophobic amino acid residues make hydrophobic cores in the protein, and many hydrophilic residues are placed on the outer surface. The structure of human renin appears to be stable from the hydrophobic and hydrophilic viewpoints. We found that many of the ionic acid residues form ion pairs with the nearby residues with an opposite charge, as listed in Table 3 .
Human renin contains 31 basic amino acid residues including Arg, Lys, and His. In contrast, penicillopepsin has only eight such residues. They are localized mainly in sheets I, IV, and V (for terminology, James and Sielecki 5 ). In the mouse renin model visualized by Blundell and colleagues 9 with interactive computer graphics techniques, Lys 89, Arg 87, and His 82 occur in the so-called flap region, which lies across the entrance to the active site cleft; in human renin, however, we found that these amino acids are replaced by Ser 89, Thr 87, and Arg 82. Only Arg 82 is included as a basic amino acid residue in the flap region of human renin. On the other hand, Lys 246, Lys 248, and Arg 249 of mouse renin are all conserved as Lys 249, Lys 250, and Arg 251, respectively, in sheet V presented in the COOH-terminal domain of human renin (for strand designation, see James and Sielecki 5 ).
Active Site Figure 4 shows the active site in human renin with the renin inhibitor (Compound HI). The two catalytically important aspartyl carboxyl groups of Asp 38 and Asp 226 are located in the center of the deep binding cleft created between the two main folding domains. Asp 38 on strand c, comes into close proximity to the Asp 226 contained in strand m,.
One of the most interesting features of the catalytic site in human renin is that the Thr 216 in penicillopepsin with its hydrogen bond to Asp 213 in the catalytic site is replaced in human renin by Ala 229, which lacks the ability to form the hydrogen bond. This residue (Thr) is conserved in other aspartic proteases. Even in mouse renin Thr is conservatively substituted by Ser 226. All residues but this one in the strand m, containing one catalytic aspartic acid seem to be conservative relative to hydrophobicity. With the exception of Val 36, the amino acid residues in strand c, of human renin, in which the alternative, aspartic acid, is located, appear to be conserved. Val 36 is in close proximity to the catalytically important aspartic acid (Asp 38), and asparagine substitutes for Val 36 in rhizopus pepsin (from Rhizopus chinensis), endothia pepsin (from Endothia parasitica), and penicillopepsin. In mouse renin and porcine pepsin this residue is isoleucine. Another important difference is that in both renins alanine (position 317 in human renin) substitutes for the Asp 300 in penicillopepsin, which is conserved in all aspartic proteases. As pointed out by Blundell and co-workers, 9 if the catalytic mechanism of renins acts in common with that of other aspartic proteases, this aspartic acid is not so essential to the catalysis.
Inhibitor-Binding Site
To deduce amino acid residues that construct the inhibitor-binding site, Boc-Phe-His-Sta-Leu-(4-amido-1-benzylpiperidine) (Compound II) was fitted to the model. This compound has been reported to be a potent 
The numbering is based on the human renin sequence. -indicates an insertion or deletion; A = alanine; E = glutamic acid; Q = glutamine;D = aspartic acid; N = asparagine; L = leucine;G = glycine; K = lysine;S = serine;V = valine;R = arginine;T = threonine; P = proline; I = isoleucine; M = methionine; F = phenylalanine; Y = tyrosine; C = cysteine; W = tryptophan; H = histidine.
The sequences of endothia pepsin and rhizopus pepsin are not chemical sequences but are derived from x-ray analysis. inhibitor of human renin with K, = 6 X 10"" M." It seems likely that some atoms in the main chain of the inhibitor form hydrogen bonds with those in human renin, and these are listed in Table 4 . These hydrogen bonds are all identified in the molecular complex between the pepstatin derivative (Compound I) and penicillopepsin.
13 Figure 3 shows the binding sites that accommodated the side chains of the inhibitor, and related amino acids are listed in Table 5 . The N a of P 2 His was hydrogen-bonded to the O r of Ser 233 of the S 2 subsite. The subsites (S) and positions (P) are indicated according to the scheme of Schechter and Berger. 20 Fehrentz and colleagues, 21 in a report on human renin inhibitors that have no histidine in the P 2 position, stated that the presence of a histidine in P 2 was not essential, as no histidine-containing compounds showed inhibitory activity. Accordingly, this hydrogen bond may not be essential for the inhibition of the renin. It has been reported that the presence of a large aromatic residue in P 3 enhanced the inhibitory activity. 21 ' a The presence of a more hydrophobic side chain in the P 3 position seems to be favorable for the inhibition because the side chain of the P 3 residue would be accommodated at the large, hydrophobic pocket constructed under the flap, as shown in Figure  4 . Phe 112 lies at the entrance of the P 3 pocket in penicillopepsin. We found that this residue was replaced by Pro 118 in human renin. Therefore, the S 3 subsite of human renin is larger than that of penicillopepsin.
The inhibitors mentioned above have an aldehyde group in common. 21 n It was assumed that the aldehydic peptides acted as transition state analogues, undergoing hydration to form a diol intermediate. 21 We constructed a model of the enzyme-inhibitor complex based on this hypothesis. The postulated two hydroxyl groups in the inhibitor were directed to the two catalytic carboxyl groups, respectively, to form hydrogen bonds in our model, as shown in Figure 4 . Recently, an x-ray study revealed that malonaldehydic acid converted into dihydroxyacetic acid in crystals from aqueous solution and that two hydroxyl groups in the molecule formed intermolecular hydrogen bonds to carboxylic groups. 23 The amino acid residues were determined by model building of the molecular complex between human renin and the inhibitor Boc-Phe-His-Sta-Uu-(4-amido-l-benzylpipendine) 
Other Characteristics
The glycosidation signal Asn-X-Thr appears to occur at residues 5-7 and 75-77 in human renin. These sequences are exposed on the surface. The side chains of Asn 5 and Asn 75, to which sugar residues are likely to be attached, protrude into the aqueous solution.
During the maturation process, mouse renin is cleaved at the Arg 290-Asp 291 bond into two chains linked by a disulfide bond. 16 24 The human counterpart (Lys 294-Leu 295) corresponding to this proteolytic cleavage site, which exists in the Cys 259-Cys 296 loop, is exposed to the surface so as to be easily accessible to as yet unidentified cleaving enzyme(s).
Conclusion
We have constructed a three-dimensional model of human renin by tracing the backbone structure of penicillopepsin. The model is consistent with several properties of human renin previously reported, and thereby indicates its usefulness and the good correlation between the model and the actual structure of human renin. Inhibitor-binding sites of the renin were assigned based on model fitting of inhibitors to the renin model, which assumed a conformation and interacting mode similar to the complex between pepstatin derivative and penicillopepsin.
The actual three-dimensional structure of human renin and the mode of interaction between inhibitors and the enzyme should be established by x-ray studies. Model building employing computer graphics seems more desirable than the physical modeling used here in view of the greater accuracy of the computer method. We constructed the tertiary model of human renin with physical models because unfortunately we could not use computer graphics systems. The use of mechanical models, however, seems to be superior to the use of computer graphics in several respects. Our techniques can be easily used, and one can readily understand the steric features of the resulting models. We believe that our model is sufficiently accurate for qualitative subjects such as those treated in this paper. Furthermore, in the development of new enzyme inhibitors, even such mechanical models offer valuable suggestions. Currently, inhibitors of human renin designed on the basis of our model are being synthesized and put through screening tests.
